Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

FH genotype stratifies LDL-C–lowering response and improves diagnostic discrimination in severe hypercholesterolemia

Severe hypercholesterolemia encompasses a broad range of phenotypes and treatment responses. Whether lipid-lowering therapy (LLT) effectiveness differs in patients with versus without pathogenic heterozygous familial hypercholesterolemia (FH) variants is not well defined, and it is uncertain if response patterns...

J. Bernhard, L. Galli, I. Undt et al. · 0 citations
Open access Oct 2026

Association of LDL-C/ApoB ratio with pathogenic variants in familial hypercholesterolemia

Familial hypercholesterolemia (FH) is an inherited disorder of lipoprotein metabolism marked by elevated low-density lipoprotein cholesterol (LDL-C) and premature atherosclerotic cardiovascular disease (ASCVD). Conventional diagnostic tools such as the Dutch Lipid Clinic Network (DLCN) score do not assess qualita...

J. Bernhard, F. Wollmann, L. Galli et al. · 0 citations
Open access Oct 2026

Treatment with PCSK9 inhibitors reduces the expression of scavenger receptors CD16, CD36 and CD45 in patients with stable coronary artery disease and elevated Lp(a) levels

Atherosclerosis is a chronic inflammatory disease driven by dyslipidemia and activation of immune system. Scavenger receptors CD16+, CD36+ and CD45+ on peripheral blood mononuclear cells (PBMCs) are involved in foam cell formation and endothelial dysfunction, promoting atherosclerosis. Although protein convertase...

S. Ugovšek, A. R. Likozar, T. Levstek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.